The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
COHERUS BIOSCIENCES INC COM 19249H103 5,171 215,381 SH   SOLE   178,916 0 36,465
COLLEGIUM PHARMACEUTICAL INC COM 19459J104 637 41,268 SH   SOLE   35,701 0 5,567
ENERGY FUELS INC COM NEW 292671708 1,202 270,177 SH   SOLE   270,177 0 30,951
SABRE CORP COM 78573M104 49,046 2,373,271 SH   SOLE   2,060,756 0 312,515
SOLAREDGE TECHNOLOGIES INC COM 83417M104 428 11,767 SH   SOLE   11,767 0 0
VERACYTE INC COM 92337F107 1,070 107,171 SH   SOLE   96,025 0 11,146
XBIOTECH INC COM 98400H102 393 25,102 SH   SOLE   21,741 0 3,361